US Stock MarketDetailed Quotes

SCPH scPharmaceuticals

Watchlist
  • 3.420
  • 0.0000.00%
Close Dec 27 16:00 ET
  • 3.450
  • +0.030+0.88%
Post 20:01 ET
171.14MMarket Cap-1.75P/E (TTM)

scPharmaceuticals Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
-29.54%-17.42M
-43.04%-20.23M
-7.32%-17.7M
-71.34%-59.24M
-28.06%-15.16M
-64.12%-13.45M
-97.09%-14.14M
-123.83%-16.49M
-27.35%-34.58M
-66.77%-11.84M
Net income from continuing operations
-124.54%-35.11M
-20.74%-17.09M
-25.85%-14.11M
-48.79%-54.81M
-49.35%-13.81M
-53.85%-15.63M
-45.96%-14.15M
-45.00%-11.21M
-31.40%-36.84M
-26.37%-9.25M
Operating gains losses
30,986.11%11.19M
555.97%1.11M
-210.23%-3.12M
-173.33%-3.65M
---2.44M
--36K
---243K
---1.01M
---1.34M
----
Depreciation and amortization
55.61%-87K
-52.29%52K
-51.43%51K
33.76%626K
406.67%608K
-266.10%-196K
-14.84%109K
2.94%105K
6.85%468K
8.11%120K
Other non cash items
1,611.63%9.57M
23.85%649K
24.95%616K
145.02%2.17M
2.61%590K
514.29%559K
403.85%524K
332.46%493K
59.57%884K
299.31%575K
Change In working capital
-687.60%-4.31M
-437.60%-6.46M
53.52%-2.48M
-1,706.00%-6.32M
79.25%-515K
-25.71%734K
-173.38%-1.2M
-980.57%-5.34M
86.53%-350K
-267.16%-2.48M
-Change in receivables
-20.90%-3.1M
-124.68%-344K
57.29%-1.28M
---4.49M
---314K
---2.57M
--1.39M
---3M
--0
--0
-Change in inventory
-118.75%-2.82M
-160.44%-5.76M
68.28%-758K
-518.62%-7.61M
-39.51%-1.72M
---1.29M
---2.21M
---2.39M
---1.23M
---1.23M
-Change in prepaid assets
-272.26%-708K
-227.89%-917K
261.69%422K
124.92%221K
61.80%-646K
8,320.00%411K
15.27%717K
-239.57%-261K
-279.06%-887K
-43.91%-1.69M
-Change in payables and accrued expense
-44.48%2.32M
150.86%560K
-371.92%-862K
214.43%5.56M
392.26%2.16M
320.85%4.18M
-208.37%-1.1M
146.55%317K
174.71%1.77M
-12.02%439K
Cash from discontinued investing activities
Operating cash flow
-29.54%-17.42M
-43.04%-20.23M
-7.32%-17.7M
-71.34%-59.24M
-28.06%-15.16M
-64.12%-13.45M
-97.09%-14.14M
-123.83%-16.49M
-27.35%-34.58M
-66.77%-11.84M
Investing cash flow
Cash flow from continuing investing activities
99.96%-9K
-99.99%1K
318.84%29.32M
143.54%19.97M
161.55%26.46M
-312.58%-22.93M
1,194.89%9.43M
154.73%7M
-242.73%-45.86M
-1,055.17%-42.99M
Net PPE purchase and sale
---9K
----
----
-90.48%-40K
---37K
--0
----
----
-133.33%-21K
--0
Net investment purchase and sale
--0
-99.99%1K
318.84%29.32M
143.64%20.01M
161.64%26.5M
-312.29%-22.93M
1,195.24%9.43M
154.76%7M
-242.62%-45.84M
-1,055.38%-42.99M
Cash from discontinued investing activities
Investing cash flow
99.96%-9K
-99.99%1K
318.84%29.32M
143.54%19.97M
161.55%26.46M
-312.58%-22.93M
1,194.89%9.43M
154.73%7M
-242.73%-45.86M
-1,055.17%-42.99M
Financing cash flow
Cash flow from continuing financing activities
103,448.53%70.41M
-53.68%283K
-99.89%15K
-80.77%14.85M
-99.45%467K
102.75%68K
125.29%611K
652.80%13.7M
3,152.53%77.23M
3,541.86%84.6M
Net issuance payments of debt
----
----
----
--0
--0
----
----
----
1,292.04%29.8M
1,592.04%37.3M
Net common stock issuance
--53.55M
--0
--0
-70.61%14.04M
--0
--0
--334K
--13.7M
--47.77M
--47.77M
Proceeds from stock option exercised by employees
-30.88%47K
2.17%283K
--15K
274.19%812K
424.72%467K
195.65%68K
229.76%277K
--0
325.49%217K
-27.64%89K
Net other financing activities
----
----
----
----
----
----
----
----
-583.95%-554K
----
Cash from discontinued financing activities
Financing cash flow
103,448.53%70.41M
-53.68%283K
-99.89%15K
-80.77%14.85M
-99.45%467K
102.75%68K
125.29%611K
652.80%13.7M
3,152.53%77.23M
3,541.86%84.6M
Net cash flow
Beginning cash position
-46.04%38.5M
-22.54%58.45M
-34.29%46.81M
-4.31%71.24M
-15.50%35.04M
72.51%71.35M
45.63%75.45M
-4.31%71.24M
3.40%74.45M
-47.84%41.47M
Current changes in cash
245.92%52.98M
-386.06%-19.94M
176.32%11.63M
-661.74%-24.43M
-60.46%11.77M
-32,809.91%-36.31M
60.74%-4.1M
118.60%4.21M
-230.95%-3.21M
688.96%29.77M
End cash Position
161.07%91.48M
-46.04%38.5M
-22.54%58.45M
-34.29%46.81M
-34.29%46.81M
-15.50%35.04M
72.51%71.35M
45.63%75.45M
-4.31%71.24M
-4.31%71.24M
Free cash flow
-29.60%-17.43M
-43.01%-20.23M
-7.32%-17.7M
-71.35%-59.28M
-28.37%-15.2M
-63.82%-13.45M
-97.13%-14.14M
-123.65%-16.49M
-27.39%-34.6M
-66.79%-11.84M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
Audit Opinions
--
--
--
Unqualified Opinion
--
--
--
--
--
--
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities -29.54%-17.42M-43.04%-20.23M-7.32%-17.7M-71.34%-59.24M-28.06%-15.16M-64.12%-13.45M-97.09%-14.14M-123.83%-16.49M-27.35%-34.58M-66.77%-11.84M
Net income from continuing operations -124.54%-35.11M-20.74%-17.09M-25.85%-14.11M-48.79%-54.81M-49.35%-13.81M-53.85%-15.63M-45.96%-14.15M-45.00%-11.21M-31.40%-36.84M-26.37%-9.25M
Operating gains losses 30,986.11%11.19M555.97%1.11M-210.23%-3.12M-173.33%-3.65M---2.44M--36K---243K---1.01M---1.34M----
Depreciation and amortization 55.61%-87K-52.29%52K-51.43%51K33.76%626K406.67%608K-266.10%-196K-14.84%109K2.94%105K6.85%468K8.11%120K
Other non cash items 1,611.63%9.57M23.85%649K24.95%616K145.02%2.17M2.61%590K514.29%559K403.85%524K332.46%493K59.57%884K299.31%575K
Change In working capital -687.60%-4.31M-437.60%-6.46M53.52%-2.48M-1,706.00%-6.32M79.25%-515K-25.71%734K-173.38%-1.2M-980.57%-5.34M86.53%-350K-267.16%-2.48M
-Change in receivables -20.90%-3.1M-124.68%-344K57.29%-1.28M---4.49M---314K---2.57M--1.39M---3M--0--0
-Change in inventory -118.75%-2.82M-160.44%-5.76M68.28%-758K-518.62%-7.61M-39.51%-1.72M---1.29M---2.21M---2.39M---1.23M---1.23M
-Change in prepaid assets -272.26%-708K-227.89%-917K261.69%422K124.92%221K61.80%-646K8,320.00%411K15.27%717K-239.57%-261K-279.06%-887K-43.91%-1.69M
-Change in payables and accrued expense -44.48%2.32M150.86%560K-371.92%-862K214.43%5.56M392.26%2.16M320.85%4.18M-208.37%-1.1M146.55%317K174.71%1.77M-12.02%439K
Cash from discontinued investing activities
Operating cash flow -29.54%-17.42M-43.04%-20.23M-7.32%-17.7M-71.34%-59.24M-28.06%-15.16M-64.12%-13.45M-97.09%-14.14M-123.83%-16.49M-27.35%-34.58M-66.77%-11.84M
Investing cash flow
Cash flow from continuing investing activities 99.96%-9K-99.99%1K318.84%29.32M143.54%19.97M161.55%26.46M-312.58%-22.93M1,194.89%9.43M154.73%7M-242.73%-45.86M-1,055.17%-42.99M
Net PPE purchase and sale ---9K---------90.48%-40K---37K--0---------133.33%-21K--0
Net investment purchase and sale --0-99.99%1K318.84%29.32M143.64%20.01M161.64%26.5M-312.29%-22.93M1,195.24%9.43M154.76%7M-242.62%-45.84M-1,055.38%-42.99M
Cash from discontinued investing activities
Investing cash flow 99.96%-9K-99.99%1K318.84%29.32M143.54%19.97M161.55%26.46M-312.58%-22.93M1,194.89%9.43M154.73%7M-242.73%-45.86M-1,055.17%-42.99M
Financing cash flow
Cash flow from continuing financing activities 103,448.53%70.41M-53.68%283K-99.89%15K-80.77%14.85M-99.45%467K102.75%68K125.29%611K652.80%13.7M3,152.53%77.23M3,541.86%84.6M
Net issuance payments of debt --------------0--0------------1,292.04%29.8M1,592.04%37.3M
Net common stock issuance --53.55M--0--0-70.61%14.04M--0--0--334K--13.7M--47.77M--47.77M
Proceeds from stock option exercised by employees -30.88%47K2.17%283K--15K274.19%812K424.72%467K195.65%68K229.76%277K--0325.49%217K-27.64%89K
Net other financing activities ---------------------------------583.95%-554K----
Cash from discontinued financing activities
Financing cash flow 103,448.53%70.41M-53.68%283K-99.89%15K-80.77%14.85M-99.45%467K102.75%68K125.29%611K652.80%13.7M3,152.53%77.23M3,541.86%84.6M
Net cash flow
Beginning cash position -46.04%38.5M-22.54%58.45M-34.29%46.81M-4.31%71.24M-15.50%35.04M72.51%71.35M45.63%75.45M-4.31%71.24M3.40%74.45M-47.84%41.47M
Current changes in cash 245.92%52.98M-386.06%-19.94M176.32%11.63M-661.74%-24.43M-60.46%11.77M-32,809.91%-36.31M60.74%-4.1M118.60%4.21M-230.95%-3.21M688.96%29.77M
End cash Position 161.07%91.48M-46.04%38.5M-22.54%58.45M-34.29%46.81M-34.29%46.81M-15.50%35.04M72.51%71.35M45.63%75.45M-4.31%71.24M-4.31%71.24M
Free cash flow -29.60%-17.43M-43.01%-20.23M-7.32%-17.7M-71.35%-59.28M-28.37%-15.2M-63.82%-13.45M-97.13%-14.14M-123.65%-16.49M-27.39%-34.6M-66.79%-11.84M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Audit Opinions ------Unqualified Opinion------------
Trending US Stocks
U.S Tech Companies U.S Tech Companies

U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
Advanced Micro Devices
AMD
+0.10%
ASML Holding
ASML
-0.32%
Meta Platforms
META
-0.59%
Cisco
CSCO
-0.62%
Intel
INTC
-0.68%

Unlock the Full List